569 related articles for article (PubMed ID: 28433332)
21. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
[TBL] [Abstract][Full Text] [Related]
22. Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction.
Henriksson R; Ulvenstam A; Söderström L; Mooe T
BMC Cardiovasc Disord; 2019 Mar; 19(1):51. PubMed ID: 30832574
[TBL] [Abstract][Full Text] [Related]
23. Depression and long-term prognostic outcomes following peripheral endovascular interventions in the VA Healthcare System.
Smolderen KG; Plomondon ME; Armstrong EJ; Hess E; Waldo S; Tsai TT; Maddox TM
Vasc Med; 2018 Oct; 23(5):454-460. PubMed ID: 29801427
[TBL] [Abstract][Full Text] [Related]
24. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
Batra G; Svennblad B; Held C; Jernberg T; Johanson P; Wallentin L; Oldgren J
Heart; 2016 Jun; 102(12):926-33. PubMed ID: 26928408
[TBL] [Abstract][Full Text] [Related]
25. Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
Melgaard L; Gorst-Rasmussen A; Rasmussen LH; Lip GY; Larsen TB
PLoS One; 2016; 11(3):e0152269. PubMed ID: 27015524
[TBL] [Abstract][Full Text] [Related]
26. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58.
Bonaca MP; Wiviott SD; Zelniker TA; Mosenzon O; Bhatt DL; Leiter LA; McGuire DK; Goodrich EL; De Mendonca Furtado RH; Wilding JPH; Cahn A; Gause-Nilsson IAM; Johanson P; Fredriksson M; Johansson PA; Langkilde AM; Raz I; Sabatine MS
Circulation; 2020 Aug; 142(8):734-747. PubMed ID: 32795086
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
[TBL] [Abstract][Full Text] [Related]
28. Effect of Cerebrovascular and/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease.
Volis I; Saliba W; Jaffe R; Eitan A; Zafrir B
Am J Cardiol; 2020 Aug; 128():28-34. PubMed ID: 32650921
[TBL] [Abstract][Full Text] [Related]
29. One-year cardiovascular event rates in outpatients with atherothrombosis.
Steg PG; Bhatt DL; Wilson PW; D'Agostino R; Ohman EM; Röther J; Liau CS; Hirsch AT; Mas JL; Ikeda Y; Pencina MJ; Goto S;
JAMA; 2007 Mar; 297(11):1197-206. PubMed ID: 17374814
[TBL] [Abstract][Full Text] [Related]
30. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
Beatty AL; Ku IA; Bibbins-Domingo K; Christenson RH; DeFilippi CR; Ganz P; Ix JH; Lloyd-Jones D; Omland T; Sabatine MS; Schiller NB; Shlipak MG; Skali H; Takeuchi M; Vittinghoff E; Whooley MA
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26150476
[TBL] [Abstract][Full Text] [Related]
31. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
Sigvant B; Henriksson M; Lundin F; Wahlberg E
Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
[TBL] [Abstract][Full Text] [Related]
32. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
33. Incidence, trends, and predictors of ischemic stroke 1 year after an acute myocardial infarction.
Ulvenstam A; Kajermo U; Modica A; Jernberg T; Söderström L; Mooe T
Stroke; 2014 Nov; 45(11):3263-8. PubMed ID: 25236874
[TBL] [Abstract][Full Text] [Related]
34. Time trends in the risk of atrial fibrillation and ischaemic stroke in patients with peripheral artery disease between 1997 and 2015.
Kamil S; Sehested T; Houlind K; Lassen J; Gislason G; Dominguez H
Open Heart; 2020 Apr; 7(1):. PubMed ID: 32354739
[TBL] [Abstract][Full Text] [Related]
35. Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization.
Jones WS; Patel MR; Tsai TT; Go AS; Gupta R; Hedayati N; Ho PM; Jazaeri O; Rehring TF; Rogers RK; Shetterly SM; Wagner NM; Magid DJ
Am Heart J; 2015 Aug; 170(2):400-8. PubMed ID: 26299239
[TBL] [Abstract][Full Text] [Related]
36. Alcohol consumption and outcome in stable outpatients with peripheral artery disease.
Garcia-Diaz AM; Marchena PJ; Toril J; Arnedo G; Muñoz-Torrero JF; Yeste M; Aguilar E; Monreal M;
J Vasc Surg; 2011 Oct; 54(4):1081-7. PubMed ID: 21684714
[TBL] [Abstract][Full Text] [Related]
37. Sex differences in the prevalence and clinical outcomes of subclinical peripheral artery disease in the Health, Aging, and Body Composition (Health ABC) study.
Hiramoto JS; Katz R; Ix JH; Wassel C; Rodondi N; Windham BG; Harris T; Koster A; Satterfield S; Newman A; Shlipak MG;
Vascular; 2014 Apr; 22(2):142-8. PubMed ID: 23512905
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
[TBL] [Abstract][Full Text] [Related]
39. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
Grenon SM; Vittinghoff E; Owens CD; Conte MS; Whooley M; Cohen BE
Vasc Med; 2013 Aug; 18(4):176-84. PubMed ID: 23835937
[TBL] [Abstract][Full Text] [Related]
40. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
